SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?


To: Baton who wrote (23692)3/28/2005 2:38:58 PM
From: Bucky Katt  Read Replies (1) | Respond to of 48463
 
Thanks for the AVII sitrep... This is interesting>
US plans to catalogue cancer genome

WASHINGTON (AFP) - US medical officials are considering a project to map the genetic anomalies linked to cancer in a new effort to combat the disease.

The Human Cancer Genome Project will be more ambitious than that undertaken to completely map the human genome, completed in 2003 after 13 years of research, New York Times reported Monday.

The cancer genome project aims to examine the DNA of thousands of tumor samples to identify the mutations which allow cancer to develop and grow, according to the report.

By comparing these samples with healthy tissue, researchers expect to create a catalogue of the genetic mutations and conditions which give rise to cancer.

Such a database would allow doctors to identify and possibly treat and prevent cancer.

"Knowing the defects of the cancer cell points you to the Achilles heel of tumors," Dr. Eric S. Lander, director of the Broad Institute, a genetic research institute near Boston, told the Times.

The proposed program will examine the DNA sequence in at least 12,500 tumor samples, 250 for each of the 50 principal types of tumor.

It would take nine years and cost an estimated 1.35 billion dollars, though the source of the funds is not yet established.
(A mere drop in the Iraqi excursion bucket, yes??)
___________

Btw, I liked how you put this>

If management can deliver results and thier Nuegene technology can block reproduction of these viruses, it's a whole new ball game for medicine, not to mention a whole new lifestyle for the Batonmeister.



To: Baton who wrote (23692)4/2/2005 12:57:41 PM
From: Henry Niman  Read Replies (1) | Respond to of 48463
 
Marburg is killing at a higher rate than Ebola. There have been NO survivors

news.google.com